These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2683358)

  • 1. Comparison of Mycoplasma gallisepticum subunit and whole organism vaccines containing different adjuvants by western immunoblotting.
    Barbour EK; Newman JA
    Vet Immunol Immunopathol; 1989 Sep; 22(2):135-44. PubMed ID: 2683358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary data on efficacy of Mycoplasma gallisepticum vaccines containing different adjuvants in laying hens.
    Barbour EK; Newman JA
    Vet Immunol Immunopathol; 1990 Oct; 26(2):115-23. PubMed ID: 2260278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and immunity in commercial chicken layers administered Mycoplasma gallisepticum liposomal bacterins.
    Barbour EK; Newman JA; Sivanandan V; Halvorson DA; Sasipreeyajan J
    Avian Dis; 1987; 31(4):723-9. PubMed ID: 3442524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterins and vaccines for the control of Mycoplasma gallisepticum.
    Kleven SH; Glisson JR; Lin MY; Talkington FD
    Isr J Med Sci; 1984 Oct; 20(10):989-91. PubMed ID: 6548986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immune response of Mycoplasma gallisepticum vaccines in poultry.
    Hussein Ael-D; El-Shaib TM; Saoud SM; Shalaby NA; Sultan H; Ragab AM
    Egypt J Immunol; 2007; 14(2):93-9. PubMed ID: 20306661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Chitosan-Adjuvanted, Mycoplasma gallisepticum Bacterin in Chickens.
    Limsatanun A; Sasipreeyajan J; Pakpinyo S
    Avian Dis; 2016 Dec; 60(4):799-804. PubMed ID: 27902896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the antigenic components of the virulent Mycoplasma gallisepticum (R) in chickens: their role in differentiation from the vaccine strain (F).
    Barbour EK; Newman JA; Sasipreeyajan J; Caputa AC; Muneer MA
    Vet Immunol Immunopathol; 1989 Jun; 21(2):197-206. PubMed ID: 2773299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine.
    Whithear KG; Soeripto ; Harrigan KE; Ghiocas E
    Aust Vet J; 1990 May; 67(5):168-74. PubMed ID: 2143068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge.
    Noormohammadi AH; Jones JE; Underwood G; Whithear KG
    Avian Dis; 2002; 46(3):623-8. PubMed ID: 12243526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity induced with an aluminum hydroxide-adsorbed Mycoplasma gallisepticum bacterin in chickens.
    Yagihashi T; Nunoya T; Tajima M
    Avian Dis; 1987; 31(1):149-55. PubMed ID: 3579785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies to Mycoplasma gallisepticum vaccine ts-11 by an autologous pMGA enzyme-linked immunosorbent assay.
    Noormohammadi AH; Browning GF; Cowling PJ; O'Rourke D; Whithear KG; Markham PF
    Avian Dis; 2002; 46(2):405-11. PubMed ID: 12061651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunity induced with a Mycoplasma gallisepticum bacterin between high- and low-responder lines of chickens.
    Yagihashi T; Nunoya T; Sannai S; Tajima M
    Avian Dis; 1992; 36(1):125-33. PubMed ID: 1567299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of chickens with temperature-sensitive mutants of Mycoplasma gallisepticum.
    Lam KM; Lin WQ; Yamamoto R; Farver TB
    Avian Dis; 1983; 27(3):803-12. PubMed ID: 6227317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate.
    Tseng CW; Chiu CJ; Kanci A; Noormohammadi AH; Browning GF; Markham PF
    Vaccine; 2017 Oct; 35(45):6248-6253. PubMed ID: 28941621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Mycoplasma gallisepticum.
    Soeripto ; Whithear KG; Cottew GS; Harrigan KE
    Aust Vet J; 1989 Mar; 66(3):73-7. PubMed ID: 2540737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the short-term and long-term efficacies of the Mycoplasma gallisepticum vaccines ts-11 and 6/85.
    Noormohammadi AH; Whithear KG
    Avian Pathol; 2019 Jun; 48(3):238-244. PubMed ID: 30773899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-adjuvanted Mycoplasma gallisepticum bacterin via intraocular administration enhances Mycoplasma gallisepticum protection in commercial layers.
    Limsatanun A; Sasipreeyajan J; Pakpinyo S
    Poult Sci; 2018 Jun; 97(6):1934-1940. PubMed ID: 29462425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of experimental inactivated mycoplasma gallisepticum oil-emulsion bacterin in egg-layer chickens.
    Yoder HW; Hopkins SR
    Avian Dis; 1985; 29(2):322-34. PubMed ID: 2992434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma gallisepticum (MG)--laboratory and field studies evaluating the safety and efficacy of an inactivated MG bacterin.
    Hildebrand DG; Page DE; Berg JR
    Avian Dis; 1983; 27(3):792-802. PubMed ID: 6688951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the immunological response of chickens to P. multocida bacterins with and without adjuvant by immunoblotting.
    Gunawardana GA; Frost AJ; Wilkie I
    Br Poult Sci; 2004 Apr; 45 Suppl 1():S40-1. PubMed ID: 15222362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.